Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Binaschi

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Molecular Pharmacology|May 1, 1994
Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistanceG Capranico, R Supino, M Binaschi, et al.
Cancer Research|May 15, 1998
Human DNA topoisomerase IIalpha-dependent DNA cleavage and yeast cell killing by anthracycline analoguesM Binaschi, R Farinosi, C A Austin, et al.
International Journal of Cancer|February 15, 1990
Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitorsM Binaschi, G Capranico, P De Isabella, et al.
International Journal of Cancer|May 8, 1993
A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicinR Supino, M Binaschi, G Capranico, et al.
International Journal of Cancer|October 15, 1990
Relationships among tumor responsiveness, cell sensitivity, doxorubicin cellular pharmacokinetics and drug-induced DNA alterations in two human small-cell lung cancer xenograftsG Pratesi, G Capranico, M Binaschi, et al.
Journal of the National Cancer Institute|November 18, 1992
Characterization of a topoisomerase II gene rearrangement in a human small-cell lung cancer cell lineM Binaschi, G Giaccone, A F Gazdar, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Anthracyclines: selected new developmentsM Binaschi, M Bigioni, A Cipollone, et al.
International Journal of Cancer|July 4, 1995
MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistanceM Binaschi, R Supino, R A Gambetta, et al.
Molecular Pharmacology|July 1, 1999
Topoisomerase poisoning activity of novel disaccharide anthracyclinesF Guano, P Pourquier, S Tinelli, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2007
Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograftM Bigioni, A Benzo, C Irrissuto, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Pharmacology|May 1, 1994
Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistanceG Capranico, R Supino, M Binaschi, et al.
Cancer Research|May 15, 1998
Human DNA topoisomerase IIalpha-dependent DNA cleavage and yeast cell killing by anthracycline analoguesM Binaschi, R Farinosi, C A Austin, et al.
International Journal of Cancer|February 15, 1990
Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitorsM Binaschi, G Capranico, P De Isabella, et al.
International Journal of Cancer|May 8, 1993
A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicinR Supino, M Binaschi, G Capranico, et al.
International Journal of Cancer|October 15, 1990
Relationships among tumor responsiveness, cell sensitivity, doxorubicin cellular pharmacokinetics and drug-induced DNA alterations in two human small-cell lung cancer xenograftsG Pratesi, G Capranico, M Binaschi, et al.
Journal of the National Cancer Institute|November 18, 1992
Characterization of a topoisomerase II gene rearrangement in a human small-cell lung cancer cell lineM Binaschi, G Giaccone, A F Gazdar, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Anthracyclines: selected new developmentsM Binaschi, M Bigioni, A Cipollone, et al.
International Journal of Cancer|July 4, 1995
MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistanceM Binaschi, R Supino, R A Gambetta, et al.
Molecular Pharmacology|July 1, 1999
Topoisomerase poisoning activity of novel disaccharide anthracyclinesF Guano, P Pourquier, S Tinelli, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2007
Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograftM Bigioni, A Benzo, C Irrissuto, et al.
Pageof 3